https://orcid.org/0000-0002-8612-8253
References
- Ernst A, Feller-Kopman D, Becker HD, et al. Central airway obstruction. Am J Respir Crit Care Med. 2004;169(12):1278–1297.
- Mehta RM, Cutaia M. The role of interventional pulmonary procedures in the management of post-obstructive pneumonia. Curr Infect Dis Rep. 2006;8(3):207–214.
- Valvani A, Martin A, Devarajan A, et al. Postobstructive pneumonia in lung cancer. Ann Transl Med. 2019;7(15):357.
- Abers M, Sandvall BP, Sampath R, et al. Postobstructive pneumonia: an underdescribed syndrome. Clin Infect Dis. 2016;62(8):957–961.
- Rolston K, Nesher L. Post-Obstructive pneumonia in patients with cancer: a review. Infect Dis Ther. 2018;7(1):29–38.
- Lee S, O’Donovan L, Cohen AJ, et al. Prevalence and treatment of postobstructive pneumonia among older adults with advanced cancer. ASHE. 2022;2(1):e152, 1–4.
- Liao WY, Liaw YS, Wang HC, et al. Bacteriology of infected cavitating lung tumor. Am J Respir Crit Care Med. 2000;161(5):1750–1753.
- Torres A, Ferrer M. Distinguishing postobstructive lung infection from Community-Acquired pneumonia. Clin Infect Dis. 2016;62(8):962–963.
- Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281.
- Quan H, Li B, Couris CM, et al. Practice of epidemiology updating and validating the charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–682.
- Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377–382.
- Charles PGP, Wolfe R, Whitby M, Australian Community-Acquired Pneumonia Study Collaboration, et al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in Community-Acquired pneumonia. Clin Infect Dis. 2008;47(3):375–384.
- Gabazza E, Taguchi O, Yamakami T, et al. Obstructive pneumonitis in lung cancer patients - a retrospective study. Nihon Kyobu Shikkan Gakkai Zasshi. 1992;30(10):1820–1824.
- Byrd RB, Carr DT, Miller WE, et al. Radiographic abnormalities in carcinoma of the lung as related to histological cell type. Thorax. 1969;24(5):573–575.
- Choi JA, Kim JH, Hong KT, et al. CT bronchus sign in malignant solitary pulmonary lesions: value in the prediction of cell type. Eur Radiol. 2000;10(8):1304–1309..
- Mortensen EM, Copeland LA, Pugh MJ, et al. Diagnosis of pulmonary malignancy after hospitalization for pneumonia. Am J Med. 2010;123(1):66–71.
- Søyseth V, Benth JS, Stavem K. The association between hospitalisation for pneumonia and the diagnosis of lung cancer. Lung Cancer. 2007;57(2):152–158.
- Moretti M, Allard SD, Dauby N, et al. Clinical features of legionnaires’ disease at three belgian university hospitals, a retrospective study. Acta Clin Belg. 2021;1:7.
- Dominguez A, Alvarez J, Sabria M, et al. Factors influencing the case-fatality rate of legionnaires’ disease. Int J Tuberc Lung Dis. 2009;13(3):407–412.
- Marti C, Garin N, Grosgurin O, et al. Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis. Crit Care. 2012;16(4):R141.
- Scott B. Multidisciplinary team approach in cancer care: a review of the latest advancements. EMJ Oncol. 2021;9(Suppl 9):2–13.
- Popat S, Navani N, Kerr KM, et al. Navigating diagnostic and treatment decisions in Non-Small cell lung cancer: expert commentary on the multidisciplinary team approach. Oncologist. 2021;26(2):e306–e315.
- Nishino M. Imaging of oncologic Treatment-Related pneumonitis: a focused review on emerging issues of immune checkpoint inhibitor pneumonitis, from the AJR special series on inflammation. AJR Am J Roentgenol. 2022;218(1):19–27.